Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis
Authors
Michael L. Mathai (ORCID: https://orcid.org/0000-0001-8783-2122)
Anthony Zulli (ORCID: https://orcid.org/0000-0002-2660-078X)
Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis
Michael L. Mathai, Anthony Zulli, Ranmali Ranasinghe
Journal
Frontiers in Endocrinology
Topics
Advanced Glycation End Products research
article
Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis
Michael L. Mathai, Anthony Zulli, Ranmali Ranasinghe
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis — Michael L. Mathai, Anthony Zulli, et al. · Frontiers in Endocrinology (2026) | TGRS Research Map | TGRS